The largest database of trusted experimental protocols

80 protocols using artemisinin

1

Quantification of Artemisinin in Leaves

Check if the same lab product or an alternative is used in the 5 most similar protocols
artemisinin content was quantified according to Nganthoi and Sanatombi (2019) (link) with slight modifications. Measurements were estimated from 6 samples, each one consisting of a pool of 2 plants. Powdered dry leaf samples (750 mg) were macerated at room temperature for 24 h with 10 ml of toluene. The filtrate was vacuum-dried using a rotary evaporator (Rotavapor® R-200, heating bath B-490, Büchi, Switzerland), and the residue was dissolved in 10 ml of extracting solvent. Then, the extract was washed with an equal volume of NaOH (2% w/v) followed by 4 washes with distilled water. To remove coloured pigments, activated charcoal was added to the extract until the colour disappeared. The filtrate was dried under vacuum and the resulting extract was dissolved in 5 mL of methanol. To prepare the standard curve, artemisinin (purity 98%, purchased from Sigma), was dissolved in methanol.
The derivatisation of artemisinin was made with 100 µl of standard artemisinin or plant extract incubated at 50°C for 30 minutes with 800 µl of 0.2% NaOH (w/v). After allowing the solution to cool to room temperature, 0.2 N HCl was added to bring the final volume to 2 ml for measurement by UV- Spectrophotometry.
+ Open protocol
+ Expand
2

Quantifying Artemisinin and DHAA in Leaves

Check if the same lab product or an alternative is used in the 5 most similar protocols
Artemisinin and DHAA levels in leaves of greenhouse-grown DT plants were determined by LC–MS/MS (Suberu et al., 2013 (link)), using an Agilent 1200 series reverse-phase C-18 column (4.6 × 100 mm × 3.5 μm) at a flow rate of 0.8 ml/min coupled with a 3200 Q TRAP linear ion trap mass spectrometer (Applied Biosystems, ABSCIEX, Singapore), equipped with a TurboIon spray source. Data were acquired and evaluated by Analyst software (version 1.6, ABSCIEX, Singapore). The MS was operated in positive mode and in MRM (Multiple Reaction Monitoring) mode. Declustering potential (DP), collision energy (CE), and collision cell exit potential (CXP) of each transition were optimized. The major MS/MS fragmentation patterns of both Artemisinin (Supplemental Figure 2A) and DHAA were determined. For optimization of MS-dependent parameters, Artemisinin (Sigma, Bengaluru, India) and DHAA (Apin Chemicals, Oxon, UK) standards in acetonitrile were injected separately using a gas-tight syringe (Harvard Apparatus, Holliston, USA). Quantification was done using MultiQuant software (Colangelo et al., 2013 (link)) and the R2 value was 0.9987.
+ Open protocol
+ Expand
3

Artemisinin Quantification in Artemisia annua

Check if the same lab product or an alternative is used in the 5 most similar protocols
All green leaves were harvested from each 2-month-old A. annua plant grown in the greenhouse under a 16-h light photoperiod at 25 ± 1 °C. The leaves were dried at 50 °C for 48 h. A 0.2-g sample of the dried leaf powder was extracted with 20 ml of petroleum ether in an ultrasonic bath for 30 min, then filtered and evaporated to dryness in a vacuum at 50 °C. Finally, the residue was re-dissolved in 5 ml of methanol. From the ensuing solution, 1 ml was passed through a 0.22-µm nylon membrane filter. The filtered solutions were then analysed using a Shimadzu LC-6AD HPLC system (Shimadzu ELSD-LTII detector). The HPLC conditions consisted of a Phenomenex C18 column that used an acetonitrile:water (60:40 v/v) mixture as the mobile phase at a flow rate of 1 ml min−1. The ELSD conditions were optimized at a nebulizer-gas pressure of 320 kPa and a drift tube temperature of 60 °C, with the gain set to 8. Authentic samples of artemisinin were bought from Sigma and used as the control in the measurements. Each sample had an injection volume of 20 µl.
+ Open protocol
+ Expand
4

Probing Plasmodium falciparum Invasion Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Highly synchronized parasites at schizont stages from P. falciparum 3D7 (transgenically expressing secretory SS-EEA1WT-mCherry) were purified using percoll density gradients. Purified schizonts were then allowed to invade fresh batch of red blood cells for 6 h. The resulting intracellular rings were exposed to mock treatment (0.1% DMSO) or the following compounds: wortmannin, LY294002, inactive LY294002 analog LY303511 (from Selleckchem), artemisinin, artesunate or dihydroartemisinin (DHA) (from Sigma-Aldrich) at the indicated concentrations in DMS0 (0.1%). Drug treatments were carried out as indicated for 30 min or 4 h. Cells were subsequently processed for live cell imaging, immunofluorescence assay (IFA) and western blotting. Drugs were removed by washing thrice with serum-free RPMI, and infected erythrocytes were imaged after 1 h. In addition, where indicated parasite growth in culture was monitored 24 h later in Giemsa smears.
+ Open protocol
+ Expand
5

Chloroquine and Artemisinin Combination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chloroquine diphosphate and artemisinin used in this study were from Sigma-Aldrich, Darmstadt, Germany.
+ Open protocol
+ Expand
6

Parasite Growth Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentration of compound able to reduce parasite growth by 50% (IC50) relative to an untreated control was measured by making 2-fold serial dilutions of compounds in the complete RPMI medium described above. Compounds at 10 mM in dimethyl sulfoxide were added (1.5 µl) to the first well in the dilution series of a 96-well plate, containing 300 µl of parasite culture at 0.25% parasitemia in 2% haematocrit. This gave a 50 µM starting concentration that was diluted 2-fold into successive wells containing 150 µl of the same parasite culture, until a concentration of 0.76 nM compound was reached. Triplicate no-treatment control wells contained 0.5% dimethyl sulfoxide (DMSO), while no-grow control wells received a mixture of 50 µM chloroquine and 50 µM artemisinin (Sigma). Plates were incubated as above for 72 h and the activity of P. falciparum lactate dehydrogenase in each well after the incubation period was quantified as a correlate of parasite numbers as previously described10 (link).
+ Open protocol
+ Expand
7

Antimalarial and Anti-Inflammatory Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Artemisinin (98%), warfarin, and ibuprofen (98%), were purchased from Sigma Aldrich (Schnelldorf, Germany).
+ Open protocol
+ Expand
8

Specific and Global PMCA Inhibitors in Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PMCA4 specific inhibitor Aurintricarboxylic acid (ATA, C22H14O9) and general PMCA inhibitor Resveratrol (C14H12O3) were used in this study. ATA, purchased from Sigma-Aldrich (Saint Louis, MO, USA), has been identified as a potent specific pharmacological inhibitor of PMCA4 [16 (link)] with IC50 of 150 nM for PMCA4 inhibition. ATA has only a minor effect on the second isoform of PMCA expressed in the heart, PMCA1 [16 (link)]. Resveratrol (trans-Resveratrol, SRT501) was purchased from SelleckChem and was identified as a potent inhibitor of global PMCA family activity [15 (link)]. All compounds were dissolved in either double distillate water (ddH2O) or dimethyl sulfoxide (DMSO) for both in vitro and in vivo experiments, and further serially diluted into a working concentration using RMPI-1640 media for in vitro. Artemisinin (Sigma Aldrich, St. Louis, Mo, USA) and sulfadoxine were used as positive control on in vitro and in vivo experiment, respectively.
+ Open protocol
+ Expand
9

Artemisinin Derivatives Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Artemisinin and 1-oleoyl-2-acetyl-sn-glycerol (OAG) were purchased from Sigma Aldrich (Munich, Germany). All other Artemisinin derivatives (artemether, artenimol, arteether, and artesunate) were from Santa Cruz Biotechnology (Heidelberg, Germany). GSK1702934A and GSK-417651A were obtained from Tebubio (Offenbach, Germany), SAR7334 hydrochloride was from MedChemexpress (Monmouth Junction, NJ, U.S.A.), and CBN 2910-0498 and BTD were from ChemDiv (San Diego, CA, U.S.A.). All other reagents were of analytical grade.
+ Open protocol
+ Expand
10

Artemisinin-Based Combination Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Artemisinin (ART), dihydroArtemisinin (DHA), linoleic acid (LA), holotransferrin (TRFi) and thiazolyl blue tetrazolium bromide were purchased from Sigma-Aldrich (St Louis, MO, USA). Fetal bovine serum (FBS), PBS, 0.25% trypsin-0.02% EDTA, and penicillin/streptomycin were supplied by Gibco BRL (San Francisco, CA, USA). High glucose medium DMEM, MEM with Earle’s balanced salt solution (EBSS), and 1 M HEPES were obtained from Thermo Scientific (Waltham, MA, USA). FITC Annexin V Apoptosis Detection Kit I and all cell culture plastics were purchased from Falcon, Becton-Dickinson (Franklin Lakes, NJ, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!